As the efficiency and efficacy of injectable treatment options improve, more patients are expected to benefit from advanced therapies.

Study identifies pro-inflammatory macrophage subtype with distinct genetic features in inflamed joints of RA patients.

AI-powered analysis of multianalyte liquid biopsies could be an accessible way to improve ovarian cancer screening.

Prime Medicine will partner with Bristol Myers Squibb (BMS) to develop and commercialize an unspecified number of reagents for ex vivo T-cell therapies through a collaboration that could generate more ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

CEO Katherine Stueland discusses company’s pivot to whole exome sequencing, whole genome sequencing tests for children with GEN Edge.